3 Patents
- US124656412025Chimeric Antigen Receptor Therapies for Treating Solid Tumors
LENTIGEN TECHNOLOGY, Inc.
0 cites - US123714902025Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites - US121228312024Compositions and Methods for Treating Cancer with Anti-cd19/cd22 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites